Target intelligence / Profile preview

Syntaxin-19 (STX19)

Target
STX19
Molecular classification
SNARE protein, Qa-SNARE, Integral membrane protein, Vesicle trafficking protein, Other
01

Overview

Syntaxin-19 is a Qa-SNARE integral membrane protein involved in the machinery of vesicle fusion, characteristic of the syntaxin family. Syntaxins possess a conserved N-terminal Habc regulatory domain, a central SNARE domain essential for complex formation, and a C-terminal transmembrane anchor. The syntaxin protein family orchestrates the specificity and dynamics of membrane fusion involved in trafficking between cellular compartments. Syntaxin-19’s precise subcellular localization, expression pattern, and function remain poorly characterized relative to prominent syntaxin isoforms like Syntaxin-1A/1B and Syntaxin-4, but likely shares core SNARE-mediated fusion mechanisms fundamental to secretion, signaling, and organelle homeostasis. Data for Syntaxin-19 is notably sparse, and most functional, molecular, or therapeutic advances in the SNARE/syntaxin family pertain to other, better-studied isoforms. No conflicting or erroneous information about the existence of STX19 as a gene/protein is apparent, but there is a lack of characterization in both the literature and therapeutic context.

Other names
STX19MGC21382syntaxin-19
02

Mechanism of action

Not applicable; drugs targeting STX19 have not been described.

03

Biological functions

General syntaxins mediate vesicle docking and fusion in exocytosis and intracellular membrane trafficking. Specific functions for Syntaxin-19 have not been described, but as a syntaxin, likely contributes to membrane fusion processes similar to other family members.
04

Disease associations

No published associations between Syntaxin-19 and specific disease states were identified in current sources. Other syntaxin family members have documented roles in neurodegeneration and immune disorders, but not STX19.

Beyond the preview

Go deeper on Syntaxin-19 (STX19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syntaxin-19 (STX19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call